TABLE 1.
Clinical characteristics of samples and their genotyping data.
| ID | Origin | Year of isolation | Material | Sexual orientation | Stage | Allelic profile (ST) | Genetic group | Macrolide resistance/sensitivity (mutation) |
| CW30* | Czechia | 2014 | genital smear | MSM | Primary | 1.3.1 (1) | SS14-like | sensitive |
| CW84 | France | 2015 | genital smear | MSW | Primary | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW85 | France | 2016 | genital smear | MSM | Primary | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW87 | France | 2016 | bucal smear | Unknown | Primary | 1.23.1 (35) | SS14-like | resistant (A2058G) |
| CW88 | Czechia | 2017 | genital smear | Unknown | Primary | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW56 | Cuba | 2013 | genital smear | MSM | Unknown | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW82 | Cuba | 2016 | genital smear | MSM | Unknown | 15.7.3 (37) | Nichols-like | sensitive |
| CW65 | Australia | 2014 | anal smear | Unknown | Secondary | 9.14.3 (47) | Nichols-like | sensitive |
| CW83 | Cuba | 2015 | genital smear | MSM | Unknown | 9.24.8 (38) | Nichols-like | sensitive |
| CW86 | France | 2013 | genital smear | MSM | Secondary | 9.20.3 (31) | Nichols-like | sensitive |
| CW59 | France | 2012 | anal smear | MSM | Secondary | 9.7.3 (26) | Nichols-like | sensitive |
| CW57 | Cuba | 2014 | genital smear | MSM | Unknown | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW51 | Cuba | 2016 | anal smear | MSM | Unknown | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW53 | Cuba | 2015 | genital smear | MSM | Unknown | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW29 | Czechia | 2013 | genital smear | MSW | Primary | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW45∗∗ | Czechia | 2013 | genital smear | WSM | Secondary | 1.26.1 (25) | SS14-like | resistant (A2058G) |
| CW89 | Czechia | 2017 | genital smear | MSW | Primary | 1.26.1 (25) | SS14-like | resistant (A2058G) |
| CW33 | Czechia | 2012 | lung | Unknown | Congenital | 1.1.8 (3) | SS14-like | sensitive |
| CW35 | Czechia | 2013 | genital smear | MSM | Primary/Secondary | 9.7.3 (26) | Nichols-like | resistant (A2058G) |
| CW31 | Czechia | 2013 | bucal smear | WSM | Secondary | 1.26.1 (25) | SS14-like | resistant (A2058G) |
| CW44∗∗ | Czechia | 2013 | bucal smear | WSM | Secondary | 1.26.1 (25) | SS14-like | resistant (A2058G) |
| CW52 | Cuba | 2016 | genital smear | MSM | Unknown | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW55 | Cuba | 2015 | skin smear | MSM | Unknown | 1.3.1 (1) | SS14-like | resistant (A2058G) |
| CW58 | France | 2013 | genital smear | unknown | Unknown | 9.7.3 (26) | Nichols-like | resistant (A2058G) |
| CW61 | Czechia | 2014 | anal smear | MSM | Primary | 1.3.1 (1) | SS14-like | resistant (A2058G) |
*Sample enriched by ATAE (Grillová et al., 2018b) prior to the DpnI enrichment. ∗∗Parallel samples taken from the same patient but isolated from different clinical material. MSM, men who have sex with men; MSW, men who have sex with women; WSM, women who have sex with men.